- Home
- AMBO vs BMRA Comparison
AMBO vs BMRA Comparison
Compare AMBO & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMBO
- BMRA
- Stock Information
- Founded
- AMBO 2000
- BMRA 1971
- Country
- AMBO United States
- BMRA United States
- Employees
- AMBO N/A
- BMRA N/A
- Industry
- AMBO Other Consumer Services
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- AMBO Real Estate
- BMRA Health Care
- Exchange
- AMBO Nasdaq
- BMRA Nasdaq
- Market Cap
- AMBO 7.2M
- BMRA 5.9M
- IPO Year
- AMBO 2010
- BMRA N/A
- Fundamental
- Price
- AMBO $2.65
- BMRA $0.84
- Analyst Decision
- AMBO
- BMRA
- Analyst Count
- AMBO 0
- BMRA 0
- Target Price
- AMBO N/A
- BMRA N/A
- AVG Volume (30 Days)
- AMBO 24.5K
- BMRA 1.5M
- Earning Date
- AMBO 12-30-2024
- BMRA 04-11-2025
- Dividend Yield
- AMBO N/A
- BMRA N/A
- EPS Growth
- AMBO N/A
- BMRA N/A
- EPS
- AMBO N/A
- BMRA N/A
- Revenue
- AMBO $7,839,000.00
- BMRA $5,578,000.00
- Revenue This Year
- AMBO N/A
- BMRA N/A
- Revenue Next Year
- AMBO N/A
- BMRA N/A
- P/E Ratio
- AMBO N/A
- BMRA N/A
- Revenue Growth
- AMBO N/A
- BMRA 1.40
- 52 Week Low
- AMBO $1.00
- BMRA $0.24
- 52 Week High
- AMBO $5.55
- BMRA $1.35
- Technical
- Relative Strength Index (RSI)
- AMBO 54.68
- BMRA 60.77
- Support Level
- AMBO $2.34
- BMRA $0.53
- Resistance Level
- AMBO $2.80
- BMRA $1.10
- Average True Range (ATR)
- AMBO 0.31
- BMRA 0.11
- MACD
- AMBO -0.02
- BMRA 0.02
- Stochastic Oscillator
- AMBO 63.82
- BMRA 61.04
About AMBO Ambow Education Holding Ltd.
Ambow Education Holding Ltd is a provider of educational and career enhancement services in China. It operates through CP&CE Programs. The CP&CE Programs include tutoring services and career enhancement services. Geographically all the operations function in the United States and Foreign countries.
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.